Sichenzia Ross Ference LLP代表A.G.P / Alliance Global Partners为Cellect Biotechnology Ltd.提供650万美元的公开募股

cellect logo

新闻稿 – 纽约州纽约市 – 2019年2月12日 – Sichenzia Ross Ference LLP今天宣布,它代表AGP
/ Alliance Global Partners担任美国存托股份(ADS)和Cellect Biotechnology Ltd认股权证的公
开发行的唯一账簿管理经理。以色列生物技术公司(纳斯达克股票代码:APOP)。国家证券公
司和道森詹姆斯证券公司担任此次发行的联合经理。

此次发行包括1,889,000手,每手包括一个ADS和一个购买一个ADS的权证,以及2,444,800手总
收益为650万美元的先行筹资的,其中包括一个先行筹资的权证和一个权证的权证。每手有效价
格为1.50美元。 Cellect开发了一种突破性技术,用于从组织中选择干细胞,旨在改善各种基于干
细胞的疗法。 Sichenzia Ross Ference团队由合伙人Gregory Sichenzia和合伙人Avital
Perlman, Jeff Cahlon律师以及Grant Levine律师领导。

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.

Visit SRF's LinkedIn page
Sichenzia Ross Ference LLP